Apogenics

Apogenics was formed in 2006 in response to a customer request for real-world healthcare market insights. Collectively, the founders had decades of experience commercializing specialty pharmaceutical and biotechnology products and were asked to advise a manufacturer for a new product launch. Since that initial project, Apogenics has advised over 10... 0 pharmaceutical, biotech, and healthcare services organizations throughout the world. Apogenics advisory model provides manufacturers, health plans, pharmacy benefit managers (PBMs), specialty pharmacies and distributors, and clinical laboratories and healthcare providers with executive level management advisory services related to commercial strategy, customer research, operational excellence, market and operational analytics, risk and regulatory compliance, and financial services. When considering patient service providers (HUBS), our team has led the market in the design and build-out, operational management, and subsequent audit analysis of all major HUB vendors in the marketplace, including manufacturer in-house HUB models. This broad experience benefits our clients as we work with both the manufacturers as well as their HUB and channel partners in developing and implementing launch strategies and measuring their value.Read More